CADPS2
Basic information
Region (hg38): 7:122318411-122886759
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CADPS2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 10 | |||||
missense | 54 | 65 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 3 | 3 | ||||
non coding | 47 | 54 | ||||
Total | 0 | 0 | 101 | 19 | 9 |
Variants in CADPS2
This is a list of pathogenic ClinVar variants found in the CADPS2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-122320353-T-G | Benign (Jan 09, 2019) | |||
7-122325503-G-A | Likely benign (Oct 23, 2018) | |||
7-122325514-T-C | not specified | Uncertain significance (May 14, 2024) | ||
7-122345638-C-T | not specified | Uncertain significance (Jul 15, 2021) | ||
7-122345647-A-G | not specified | Uncertain significance (May 30, 2024) | ||
7-122345657-T-A | not specified | Uncertain significance (Dec 13, 2022) | ||
7-122360793-C-T | not specified | Uncertain significance (Apr 07, 2023) | ||
7-122360944-T-G | not specified | Uncertain significance (Oct 27, 2023) | ||
7-122360968-C-T | not specified | Uncertain significance (Nov 10, 2022) | ||
7-122379433-G-A | not specified | Uncertain significance (May 23, 2023) | ||
7-122387040-C-G | not specified | Uncertain significance (Feb 06, 2023) | ||
7-122387076-C-T | CADPS2-related disorder | Likely benign (Dec 31, 2019) | ||
7-122387103-C-T | CADPS2-related disorder | Uncertain significance (May 29, 2024) | ||
7-122388635-C-G | not specified | Uncertain significance (Feb 16, 2023) | ||
7-122388696-A-T | not specified | Uncertain significance (Mar 17, 2023) | ||
7-122388719-C-T | Benign (Dec 31, 2019) | |||
7-122393222-C-T | Likely benign (Mar 01, 2024) | |||
7-122393223-G-A | not specified | Uncertain significance (Dec 15, 2022) | ||
7-122393229-G-T | not specified | Uncertain significance (Jan 11, 2023) | ||
7-122393451-G-C | Likely benign (Jun 23, 2018) | |||
7-122393458-C-A | not specified | Uncertain significance (Feb 06, 2023) | ||
7-122393490-C-T | not specified | Uncertain significance (Apr 13, 2022) | ||
7-122393535-C-T | not specified | Uncertain significance (May 31, 2023) | ||
7-122393555-T-C | not specified | Uncertain significance (Feb 22, 2023) | ||
7-122407578-G-C | not specified | Uncertain significance (Apr 04, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CADPS2 | protein_coding | protein_coding | ENST00000449022 | 30 | 568333 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.368 | 0.632 | 124642 | 0 | 37 | 124679 | 0.000148 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.09 | 561 | 639 | 0.878 | 0.0000320 | 8445 |
Missense in Polyphen | 128 | 183.71 | 0.69676 | 2391 | ||
Synonymous | 0.570 | 222 | 233 | 0.953 | 0.0000120 | 2375 |
Loss of Function | 6.03 | 16 | 70.7 | 0.226 | 0.00000358 | 918 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000214 | 0.000212 |
Ashkenazi Jewish | 0.0000996 | 0.0000993 |
East Asian | 0.000170 | 0.000167 |
Finnish | 0.000140 | 0.000139 |
European (Non-Finnish) | 0.000198 | 0.000195 |
Middle Eastern | 0.000170 | 0.000167 |
South Asian | 0.0000342 | 0.0000327 |
Other | 0.000187 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: Calcium-binding protein involved in exocytosis of vesicles filled with neurotransmitters and neuropeptides. Probably acts upstream of fusion in the biogenesis or maintenance of mature secretory vesicles. Regulates neurotrophin release from granule cells leading to regulate cell differentiation and survival during cerebellar development. May specifically mediate the Ca(2+)- dependent exocytosis of large dense-core vesicles (DCVs) and other dense-core vesicles (By similarity). {ECO:0000250}.;
Recessive Scores
- pRec
- 0.123
Intolerance Scores
- loftool
- rvis_EVS
- -0.66
- rvis_percentile_EVS
- 16.02
Haploinsufficiency Scores
- pHI
- 0.451
- hipred
- Y
- hipred_score
- 0.544
- ghis
- 0.571
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.734
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cadps2
- Phenotype
- growth/size/body region phenotype; endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- cellular response to starvation;protein transport;synaptic vesicle priming;positive regulation of exocytosis;dense core granule exocytosis
- Cellular component
- nucleoplasm;cell junction;cytoplasmic vesicle membrane;presynaptic membrane;intracellular membrane-bounded organelle;postsynaptic membrane;parallel fiber to Purkinje cell synapse;glutamatergic synapse
- Molecular function
- lipid binding;metal ion binding